342 related articles for article (PubMed ID: 17573792)
1. The model for end-stage liver disease based cancer staging systems are better prognostic models for hepatocellular carcinoma: a prospective sequential survey.
Huo TI; Lin HC; Hsia CY; Wu JC; Lee PC; Chi CW; Lee SD
Am J Gastroenterol; 2007 Sep; 102(9):1920-30. PubMed ID: 17573792
[TBL] [Abstract][Full Text] [Related]
2. The model for end-stage liver disease-based Japan Integrated Scoring system may have a better predictive ability for patients with hepatocellular carcinoma undergoing locoregional therapy.
Huo TI; Lin HC; Huang YH; Wu JC; Chiang JH; Lee PC; Lee SD
Cancer; 2006 Jul; 107(1):141-8. PubMed ID: 16708358
[TBL] [Abstract][Full Text] [Related]
3. Selecting a short-term prognostic model for hepatocellular carcinoma: comparison between the model for end-stage liver disease (MELD), MELD-sodium, and five cancer staging systems.
Huo TI; Hsia CY; Huang YH; Lin HC; Lee PC; Lui WY; Chiang JH; Chiou YY; Loong CC; Lee SD
J Clin Gastroenterol; 2009 Sep; 43(8):773-81. PubMed ID: 19262404
[TBL] [Abstract][Full Text] [Related]
4. Proposal of a modified Cancer of the Liver Italian Program staging system based on the model for end-stage liver disease for patients with hepatocellular carcinoma undergoing loco-regional therapy.
Huo TI; Huang YH; Lin HC; Wu JC; Chiang JH; Lee PC; Chang FY; Lee SD
Am J Gastroenterol; 2006 May; 101(5):975-82. PubMed ID: 16573785
[TBL] [Abstract][Full Text] [Related]
5. Prognostic staging system for hepatocellular carcinoma (CLIP score): its value and limitations, and a proposal for a new staging system, the Japan Integrated Staging Score (JIS score).
Kudo M; Chung H; Osaki Y
J Gastroenterol; 2003; 38(3):207-15. PubMed ID: 12673442
[TBL] [Abstract][Full Text] [Related]
6. Comparison of clinical staging systems in predicting survival of hepatocellular carcinoma patients receiving major or minor hepatectomy.
Chen TW; Chu CM; Yu JC; Chen CJ; Chan DC; Liu YC; Hsieh CB
Eur J Surg Oncol; 2007 May; 33(4):480-7. PubMed ID: 17129701
[TBL] [Abstract][Full Text] [Related]
7. Validation of a new prognostic staging system for hepatocellular carcinoma: the JIS score compared with the CLIP score.
Kudo M; Chung H; Haji S; Osaki Y; Oka H; Seki T; Kasugai H; Sasaki Y; Matsunaga T
Hepatology; 2004 Dec; 40(6):1396-405. PubMed ID: 15565571
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of model for end stage liver disease (MELD)-based systems as prognostic index for hepatocellular carcinoma.
Limquiaco JL; Wong GL; Wong VW; Lai PB; Chan HL
J Gastroenterol Hepatol; 2009 Jan; 24(1):63-9. PubMed ID: 19054256
[TBL] [Abstract][Full Text] [Related]
9. The MELD-Na is an independent short- and long-term prognostic predictor for hepatocellular carcinoma: a prospective survey.
Huo TI; Lin HC; Hsia CY; Huang YH; Wu JC; Chiang JH; Chiou YY; Lui WY; Lee PC; Lee SD
Dig Liver Dis; 2008 Nov; 40(11):882-9. PubMed ID: 18339595
[TBL] [Abstract][Full Text] [Related]
10. Value of the model for end-stage liver disease for predicting survival in hepatocellular carcinoma patients treated with transarterial chemoembolization.
Kim JH; Kim JH; Choi JH; Kim CH; Jung YK; Yim HJ; Yeon JE; Park JJ; Kim JS; Bak YT; Byun KS
Scand J Gastroenterol; 2009; 44(3):346-57. PubMed ID: 18991165
[TBL] [Abstract][Full Text] [Related]
11. Comparative study of survival of patients with hepatocellular carcinoma predicted by different staging systems using multivariate analysis.
Nanashima A; Omagari K; Tobinaga S; Shibata K; Sumida Y; Mine M; Morino S; Shibasaki S; Ide N; Shindou H; Nagayasu T
Eur J Surg Oncol; 2005 Oct; 31(8):882-90. PubMed ID: 15993031
[TBL] [Abstract][Full Text] [Related]
12. Selecting an optimal staging system for hepatocellular carcinoma: comparison of 5 currently used prognostic models.
Hsu CY; Hsia CY; Huang YH; Su CW; Lin HC; Lee PC; Loong CC; Chiang JH; Huo TI; Lee SD
Cancer; 2010 Jun; 116(12):3006-14. PubMed ID: 20564406
[TBL] [Abstract][Full Text] [Related]
13. Proposal of a modified Child-Turcotte-Pugh scoring system and comparison with the model for end-stage liver disease for outcome prediction in patients with cirrhosis.
Huo TI; Lin HC; Wu JC; Lee FY; Hou MC; Lee PC; Chang FY; Lee SD
Liver Transpl; 2006 Jan; 12(1):65-71. PubMed ID: 16382473
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of predictive value of CLIP, Okuda, TNM and JIS staging systems for hepatocellular carcinoma patients undergoing surgery.
Huang YH; Chen CH; Chang TT; Chen SC; Wang SY; Lee HS; Lin PW; Huang GT; Sheu JC; Tsai HM; Lee PC; Chau GY; Lui WY; Lee SD; Wu JC
J Gastroenterol Hepatol; 2005 May; 20(5):765-71. PubMed ID: 15853992
[TBL] [Abstract][Full Text] [Related]
15. Validation of model for end-stage liver disease score to serum sodium ratio index as a prognostic predictor in patients with cirrhosis.
Lv XH; Liu HB; Wang Y; Wang BY; Song M; Sun MJ
J Gastroenterol Hepatol; 2009 Sep; 24(9):1547-53. PubMed ID: 19686416
[TBL] [Abstract][Full Text] [Related]
16. Prospective validation of the Barcelona Clinic Liver Cancer staging system.
Cillo U; Vitale A; Grigoletto F; Farinati F; Brolese A; Zanus G; Neri D; Boccagni P; Srsen N; D'Amico F; Ciarleglio FA; Bridda A; D'Amico DF
J Hepatol; 2006 Apr; 44(4):723-31. PubMed ID: 16488051
[TBL] [Abstract][Full Text] [Related]
17. Comparison of seven staging systems in cirrhotic patients with hepatocellular carcinoma in a cohort of patients who underwent radiofrequency ablation with complete response.
Guglielmi A; Ruzzenente A; Pachera S; Valdegamberi A; Sandri M; D'Onofrio M; Iacono C
Am J Gastroenterol; 2008 Mar; 103(3):597-604. PubMed ID: 17970836
[TBL] [Abstract][Full Text] [Related]
18. Comparison of the usefulness of three staging systems for hepatocellular carcinoma (CLIP, BCLC, and JIS) in Japan.
Toyoda H; Kumada T; Kiriyama S; Sone Y; Tanikawa M; Hisanaga Y; Yamaguchi A; Isogai M; Kaneoka Y; Washizu J
Am J Gastroenterol; 2005 Aug; 100(8):1764-71. PubMed ID: 16086713
[TBL] [Abstract][Full Text] [Related]
19. A modified TNM-based Japan Integrated Score combined with AFP level may serve as a better staging system for early-stage predominant hepatocellular carcinoma patients.
Yen YH; Changchien CS; Wang JH; Kee KM; Hung CH; Hu TH; Lee CM; Lin CY; Wang CC; Chen TY; Huang YJ; Lu SN
Dig Liver Dis; 2009 Jun; 41(6):431-41. PubMed ID: 19185555
[TBL] [Abstract][Full Text] [Related]
20. Comparison of seven prognostic staging systems in patients who undergo hepatectomy for hepatocellular carcinoma.
Kondo K; Chijiiwa K; Nagano M; Hiyoshi M; Kai M; Maehara N; Ohuchida J; Nakao H; Ohkuwa Y
Hepatogastroenterology; 2007; 54(77):1534-8. PubMed ID: 17708292
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
